Filing Details

Accession Number:
0001193125-17-043686
Form Type:
13G Filing
Publication Date:
2017-02-14 16:54:50
Filed By:
S&r Technology Holdings, Llc
Company:
Sucampo Pharmaceuticals Inc. (NASDAQ:SCMP)
Filing Date:
2017-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
S R TECHNOLOGY HOLDINGS 0 0 0 0 0 0.0%
Filing

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

Amendment No. 8

 

 

SUCAMPO PHARMACEUTICALS, INC.

(Name of Issuer)

CLASS A COMMON STOCK

(Title of Class of Securities)

864909106

(CUSIP Number)

DECEMBER 31, 2016

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☐ Rule 13d-1(c)

☒ Rule 13d-1(d)

Check the following box if a fee is being paid with this statement.  ☐

 

 

 


  CUSIP No.: 864909106  

 

  (1)   

Name of Reporting Person

 

S&R TECHNOLOGY HOLDINGS, LLC

 

I.R.S. Identification No. of Above Person

 

52-2242847

  (2)  

Check the Appropriate Box if a Member of a Group

(a)  ☐        (b)  ☐

 

  (3)  

SEC Use Only

 

  (4)  

Citizenship

 

DELAWARE

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person

With

   (5)    

Sole Voting Power

 

0

   (6)   

Shared Voting Power

 

0

   (7)   

Sole Dispositive Power

 

0

   (8)   

Shared Dispositive Power

 

0

  (9)  

Aggregate Amount Beneficially Owned by Each Reporting Person

 

0

(10)  

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐

 

(11)  

Percent of Class Represented by Amount in Row (9)

 

0.0%

(12)  

Type of Reporting Person

 

OO

 

 

2


Item 1(a). Name of Issuer

SUCAMPO PHARMACEUTICALS, INC.

 

Item 1(b). Address of Issuers Principal Executive Offices

805 KING FARM BOULEVARD, SUITE 550

ROCKVILLE, MD 20850

 

Item 2(a). Name of Person Filing

S&R TECHNOLOGY HOLDINGS, LLC

 

Item 2(b). Address of Principal Business Office or, if none, Residence

18625 RIVER ROAD

POOLESVILLE, MD 20837

 

Item 2(c). Citizenship

DELAWARE

 

Item 2(d). Title of Class of Securities

CLASS A COMMON STOCK

 

Item 2(e). CUSIP No.

864909106

 

Item 3. If this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b) or (c):

NOT APPLICABLE

 

Item 4. Ownership

 

  (a) Amount beneficially owned:

0

 

  (b) Percent of class:

0.0%

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote:

0

 

3


  (ii) Shared power to vote or to direct the vote:

0

 

  (iii) Sole power to dispose or to direct the disposition of:

0

 

  (iv) Shared power to dispose or to direct the disposition of:

0

 

Item 5. Ownership of Five Percent or Less of a Class

 

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

NOT APPLICABLE

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

NOT APPLICABLE

 

Item 8. Identification and Classification of Members of the Group

NOT APPLICABLE

 

Item 9. Notice of Dissolution of Group

NOT APPLICABLE

 

Item 10. Certifications

NOT APPLICABLE

 

4


SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 14, 2017     S&R TECHNOLOGY HOLDINGS, LLC
    By:  

/s/ Kei Tolliver

    Name:   Kei Tolliver
      Secretary

 

5